Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.
about
Intravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progressionTumor-intrinsic oncogene pathways mediating immune avoidanceSignaling in T cells - is anything the m(a)TOR with the picture(s)?Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyTumor-infiltrating dendritic cells in cancer pathogenesisDendritic cells: arbiters of immunity and immunological toleranceIn Vivo Visualization of Tumor Antigen-containing Microparticles Generated in Fluorescent-protein-elicited Immunity.Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte MigrationGenetically engineered mouse models in oncology research and cancer medicineOxidized lipids block antigen cross-presentation by dendritic cells in cancerIntravital Microscopy Imaging Approaches for Image-Guided Drug Delivery SystemsCD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network.An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and functionIntravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations.Intravital and whole-organ imaging reveals capture of melanoma-derived antigen by lymph node subcapsular macrophages leading to widespread deposition on follicular dendritic cells.Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.Development of novel murine mammary imaging windows to examine wound healing effects on leukocyte trafficking in mammary tumors with intravital imaging.Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.The cellular and molecular origin of tumor-associated macrophages.Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunityChemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effectsThe emerging understanding of myeloid cells as partners and targets in tumor rejection.Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion.Intratumoral dendritic cells in the anti-tumor immune responseTumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.Adaptive Immune Regulation of Mammary Postnatal OrganogenesisDirecting the assembly of spatially organized multicomponent tissues from the bottom up.Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κBAn evolutionary perspective on anti-tumor immunityTargeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responsesThymic stromal lymphopoietin blocks early stages of breast carcinogenesis.Live imaging of drug responses in the tumor microenvironment in mouse models of breast cancer.Role of dendritic cells in the regulation of antitumor immunityAntitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment.Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks.Imaging interactions between macrophages and tumour cells that are involved in metastasis in vivo and in vitro.Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations.
P2860
Q26745311-C1EE02C1-2A09-420C-8699-F374E27D4D71Q26747707-6C7D6BF5-F769-493D-86D5-83F599A20A2DQ26767443-FFDDED20-2C99-4DB2-A64E-79DE51782E03Q26779184-F3311726-DA96-4F79-BA80-861B6E7B03CBQ26861633-8B4D45E5-C8D1-4299-A1CF-8A27FC9555A8Q27001626-08E60225-4C38-47C0-9AE5-C3166A96A103Q27300824-5C436E8A-264D-417E-92AD-CC27E68C0ACAQ27329768-D7472A74-2D8B-41E9-B898-6DE7E7642E27Q28079323-3FCA2F51-C011-4D76-8312-11273917949EQ28384581-DBB1D030-5D97-47A1-B819-ACFC5701A4EAQ28553638-0485C84F-523B-4379-8227-BF82EB5B968CQ30533257-E68C0E61-15BE-4D70-94B1-B7671D03C1B1Q30582456-542C4DEA-DF58-457A-A560-BEC1A3EF0FABQ30603919-EE91BF8E-0541-4422-818C-046976791B2CQ30627418-2037ED4B-AAA4-44DC-B13B-83AA81A087F8Q30830664-D30A39D2-6583-4AFC-930B-174C6F18189EQ30834635-76222B04-6677-4EC3-B3AF-EA8337CD1CB0Q30843481-8FE43195-06A7-43DA-8FD3-506A8748AF32Q34279134-FD820DB9-4DA5-44D1-9B5B-81D8923D70D3Q34378833-06FCBCC5-15B0-40D0-9DD2-6B8AD3AB75E0Q34625640-6647856A-2A94-430C-83FE-836E05F9C14CQ35013696-7F49382F-D85B-458C-8C44-9710D00CA13FQ35338729-702587E5-2876-4FDC-9172-F508BD9FB42BQ35798899-D31D06D3-89DE-435B-B3AF-2096E4A94855Q35833610-9FA4671C-04D4-4EAD-B352-257A46990325Q35938555-DDED0DB3-ED64-43DD-9710-35EB45A64013Q36070571-4B146ADB-E6F1-41FF-9B06-782A6F5FA8AEQ36420075-7623BC3C-5F90-48BA-ACE7-C3234F1DDAF1Q36453386-41DCEC82-AF1E-4158-B7B9-66FB9D1E26C1Q36471523-356AFF7C-33F8-4E1B-9356-40C13486E7EEQ36522859-E8705887-7F63-40D1-B300-445D72C53D95Q36586333-84D67347-C40A-48A3-803A-09DDB872CAF4Q36737874-8D09B562-B98A-445C-A197-FDA580B2904DQ36805080-41BAA69C-D00F-441E-BAA7-EA2A307CF7E6Q36845842-2C0F578B-929F-41EB-8B07-B02BC0E6CF27Q37452252-9F068A27-4543-4A02-A228-3CA4DA7FD856Q37542092-90785CB2-3975-41BA-9300-C9FE6ED83AA4Q37693754-E12C081C-6460-4E59-84DD-8C784FEAE3E2Q37723869-7A3E0954-0700-401C-BBF1-CAE87CBE98FDQ38061429-A7510381-C1A8-4AB3-8F30-38FE13597EDD
P2860
Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Marginating dendritic cells of ...... engage tumor-specific T cells.
@ast
Marginating dendritic cells of ...... engage tumor-specific T cells.
@en
type
label
Marginating dendritic cells of ...... engage tumor-specific T cells.
@ast
Marginating dendritic cells of ...... engage tumor-specific T cells.
@en
prefLabel
Marginating dendritic cells of ...... engage tumor-specific T cells.
@ast
Marginating dendritic cells of ...... engage tumor-specific T cells.
@en
P2093
P2860
P50
P1433
P1476
Marginating dendritic cells of ...... engage tumor-specific T cells.
@en
P2093
Caitlin Sorensen
John J Engelhardt
Matthew F Krummel
Priya Pandurangi
P2860
P304
P356
10.1016/J.CCR.2012.01.008
P577
2012-03-01T00:00:00Z